Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes. 1994

P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
Department of Obstetrics and Gynaecology, Rigshospitalet, University of Copenhagen, Denmark.

The objective of the present study was to investigate the predictive value of islet cell antibodies (ICA) and insulin autoantibodies (IAA) for development of diabetes in women with previous gestational diabetes (GDM). Two hundred and forty-one previous diet-treated GDM patients and 57 women without previous GDM were examined 2-11 years after the index pregnancy. In subgroups, plasma from the diagnostic OGTT during index pregnancy was analysed for ICA and IAA. Among the previous GDM patients, 3.7% had developed Type 1 diabetes and 13.7% Type 2 diabetes. Four (2.9%) of the 139 GDM patients tested for ICA were ICA-positive and three of these had Type 1 diabetes at follow-up, as well as three ICA-negative patients. The sensitivity, specificity, and predictive value of ICA-positivity for later development of diabetes were 50%, 99%, and 75%, respectively. None of the women was IAA-positive during pregnancy. In conclusion, the majority of the patients with GDM did not show evidence of ongoing autoimmune destruction of the beta cells during the index pregnancy. However, ICA-positive GDM patients had a high risk of developing Type 1 diabetes later in life.

UI MeSH Term Description Entries
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
July 1999, The Journal of clinical endocrinology and metabolism,
P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
January 1997, Diabetes care,
P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
October 1990, Zhonghua nei ke za zhi,
P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
May 1990, Diabetes care,
P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
January 1989, Klinische Wochenschrift,
P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
May 1986, Diabetologia,
P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
October 2007, Diabetes research and clinical practice,
P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
December 1996, Diabetes/metabolism reviews,
P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
October 1985, The New England journal of medicine,
P Damm, and C Kühl, and K Buschard, and B K Jakobsen, and A Svejgaard, and F Sodoyez-Goffaux, and M Shattock, and G F Bottazzo, and L Mølsted-Pedersen
November 1981, Human immunology,
Copied contents to your clipboard!